Friday, April 29, 2016

AstraZeneca's Investment Eats Into Profit

AstraZeneca said core profit fell in the first quarter even as revenue rose, as it plowed heavy investment into the development of a string of new drugs it is betting on for growth.

from WSJ.com: US Business http://ift.tt/1rmSMrY
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)